0001567619-22-011902.txt : 20220531
0001567619-22-011902.hdr.sgml : 20220531
20220531123828
ACCESSION NUMBER: 0001567619-22-011902
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220527
FILED AS OF DATE: 20220531
DATE AS OF CHANGE: 20220531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buesinger Robert F.
CENTRAL INDEX KEY: 0001488587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32260
FILM NUMBER: 22981789
MAIL ADDRESS:
STREET 1: 2801 POST OAK BLVD, SUITE 600
CITY: HOUSTON
STATE: TX
ZIP: 77056
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WESTLAKE CORP
CENTRAL INDEX KEY: 0001262823
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 760346924
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 POST OAK BLVD
STREET 2: SUITE 600
CITY: HOUSTON
STATE: TX
ZIP: 77056
BUSINESS PHONE: 713-960-9111
MAIL ADDRESS:
STREET 1: 2801 POST OAK BLVD
STREET 2: SUITE 600
CITY: HOUSTON
STATE: TX
ZIP: 77056
FORMER COMPANY:
FORMER CONFORMED NAME: WESTLAKE CHEMICAL CORP
DATE OF NAME CHANGE: 20030908
4
1
doc1.xml
FORM 4
X0306
4
2022-05-27
0
0001262823
WESTLAKE CORP
WLK
0001488587
Buesinger Robert F.
2801 POST OAK BOULEVARD, SUITE 600
HOUSTON
TX
77056
0
1
0
0
EVP, HIP, IT & Digital
Common Stock
2022-05-27
4
M
0
9571
107.75
A
21351
D
Common Stock
2022-05-27
4
M
0
4856
86.5379
A
26207
D
Common Stock
2022-05-27
4
S
0
14427
129.467
D
11780
D
Employee Option (right to buy)
107.75
2022-05-27
4
M
0
9571
0
D
2028-02-16
Common Stock
9571
0
D
Employee Option (right to buy)
86.5379
2022-05-27
4
M
0
4856
0
D
2031-02-19
Common Stock
4856
9862
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $129.45 to $129.72, inclusive. The reporting person undertakes to provide to Westlake Corporation, any security holder of Westlake Chemical Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The stock options were excercisable in three installments of 33%, 33% and 34% on February 16, 2019, 2020 and 2021, respectively.
The stock options were excercisable in three installments of 33%, 33% and 34% on February 19, 2022, 2023 and 2024, respectively.
Robert F. Buesinger by J. Feng POA
2022-05-31